Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Encompass Health Corporation, Astrana Health or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Encompass Health Corporation, Astrana Health and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Encompass Health Corporation, Astrana Health and Inc.

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Latest Health Care Providers & Services and Encompass Health Corporation, Astrana Health, Inc. Stock News

As of July 31, 2026, Encompass Health Corporation had a $11.0 billion market capitalization, compared to the Health Care Providers & Services median of $1.7 million. Encompass Health Corporation’s stock is up 4.6% in 2026, down 1.6% in the previous five trading days and up 1.01% in the past year.

Currently, Encompass Health Corporation’s price-earnings ratio is 19.0. Encompass Health Corporation’s trailing 12-month revenue is $6.1 billion with a 10.0% net profit margin. Year-over-year quarterly sales growth most recently was 9.0%. Analysts expect adjusted earnings to reach $6.005 per share for the current fiscal year. Encompass Health Corporation currently has a 0.7% dividend yield.

As of July 31, 2026, Astrana Health, Inc. had a $1.6 billion market cap, putting it in the 51st percentile of all stocks. Astrana Health, Inc.’s stock is up 43.3% in 2026, down 11.8% in the previous five trading days and up 47.67% in the past year.

Currently, Astrana Health, Inc.’s price-earnings ratio is 58.4. Astrana Health, Inc.’s trailing 12-month revenue is $3.5 billion with a 0.9% net profit margin. Year-over-year quarterly sales growth most recently was 55.6%. Analysts expect adjusted earnings to reach $2.920 per share for the current fiscal year. Astrana Health, Inc. does not currently pay a dividend.

How We Compare Encompass Health Corporation, Astrana Health and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Encompass Health Corporation, Astrana Health and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Encompass Health Corporation, Astrana Health and Inc. Stock Value Grades

Company	Ticker	Value
Encompass Health Corporation	EHC	C
Astrana Health, Inc.	ASTH	C

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Encompass Health Corporation has a Value Score of 46, which is Average. Astrana Health, Inc. has a Value Score of 52, which is Average.

The Value Stock Winner: No Clear Winner

Neither Encompass Health Corporation, Astrana Health or Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Encompass Health Corporation, Astrana Health or Inc. is the better investment when it comes to value.

Encompass Health Corporation, Astrana Health and Inc. Growth Grades

Company	Ticker	Growth
Encompass Health Corporation	EHC	A
Astrana Health, Inc.	ASTH	B

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Encompass Health Corporation has a Growth Score of 89, which is Very Strong. Astrana Health, Inc. has a Growth Score of 69, which is Strong.

The Growth Grade Winner: Encompass Health Corporation

As you can clearly see from the Growth Grade breakdown above, Encompass Health Corporation has a more attractive growth grade than Astrana Health, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Encompass Health Corporation could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Encompass Health Corporation, Astrana Health and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Encompass Health Corporation	EHC	C
Astrana Health, Inc.	ASTH	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Encompass Health Corporation has a Earnings Estimate Score of 60, which is Neutral. Astrana Health, Inc. has a Earnings Estimate Score of 55, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither Encompass Health Corporation, Astrana Health or Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Encompass Health Corporation, Astrana Health or Inc. is the better investment when it comes to estimate revisions.

Other Encompass Health Corporation, Astrana Health and Inc. Grades

In addition to Value, Growth and Estimate Revisions, A+ Investor also provides grades for Momentum and Quality.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Encompass Health Corporation, Astrana Health and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Encompass Health Corporation, Astrana Health or Inc. Stock?

Overall, Encompass Health Corporation stock has a Value Score of 46, Growth Score of 89 and Estimate Revisions Score of 60.

Astrana Health, Inc. stock has a Value Score of 52, Growth Score of 69 and Estimate Revisions Score of 55.

Comparing Encompass Health Corporation, Astrana Health and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.